MCMedicalCodingSoftware
Free trial
XW0G738

XW0G738 — Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce of Maribavir into Up GI, Via Opening, New Tech 8

How XW0G738 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology — What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. GBody partThe specific site
  5. 7ApproachHow the site was reached
  6. 3DeviceWhat was left in place, if anything
  7. 8QualifierA further distinction where one applies

Codes near XW0G738

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • XW0DX82Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
  • XW0DXF5Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5
  • XW0DXJ9Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXK8Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8
  • XW0DXM6Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6
  • XW0DXN9Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
  • XW0DXR7Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
  • XW0DXVBIntroduction of Xanomeline and Trospium Chloride into Mouth and Pharynx, External Approach, New Technology Group 11
  • XW0G738Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0G7K8Introduction of Sabizabulin into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0G7M6Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6
  • XW0G7R7Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
  • XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
  • XW0H738Introduction of Maribavir Anti-infective into Lower GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0H7K8Introduction of Sabizabulin into Lower GI, Via Natural or Artificial Opening, New Technology Group 8
  • XW0H7M6Introduction of Baricitinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 6
  • XW0H7R7Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7
ICD-10-PCSFY2026